FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990444499> ?p ?o ?g. }

• W1990444499 endingPage "195" @default.
• W1990444499 startingPage "180" @default.
• W1990444499 abstract "BackgroundThe inhaled corticosteroid, fluticasone propionate, and the long-acting β2-adrenergic agonist, formoterol fumarate, are both highly effective treatments for bronchial asthma. This study (NCT00393952/EudraCT number: 2006-005989-39) compared the efficacy and safety of fluticasone/formoterol combination therapy (flutiform®; 250/10 μg) administered twice daily (b.i.d.) via a single aerosol inhaler, with the individual components (fluticasone 250 μg b.i.d.; formoterol 10 μg b.i.d.), in adult and adolescent patients with moderate-to-severe asthma.MethodsThis was a 12-week, double-blind, randomised, parallel-group, multicentre, placebocontrolled phase 3 study. The co-primary efficacy endpoints were: i) the mean change in the forced expiratory volume in the first second (FEV1) from morning pre-dose at baseline to pre-dose at week 12 (fluticasone/formoterol 250/10 μg vs. formoterol), ii) the mean change in FEV1 from morning pre-dose at baseline to 2 h post-dose at week 12 (fluticasone/formoterol 250/10 μg vs. fluticasone), and iii) the number of patients who discontinued prematurely due to lack of treatment efficacy (fluticasone/formoterol 250/10 μg vs. placebo). The secondary endpoints included measures of lung function, disease control, and asthma symptoms. Safety was assessed based on adverse events, vital signs, and clinical laboratory evaluations.ResultsOverall, 395 (70.9%) patients completed the study. Fluticasone/formoterol 250/10 μg b.i.d. was superior to the individual components and placebo for all three co-primary endpoints and demonstrated numerically greater improvements for multiple secondary efficacy analyses. Fluticasone/formoterol combination therapy had a good safety profile over the 12 weeks.ConclusionFluticasone/formoterol combination therapy will provide clinicians with an efficacious alternative treatment option for patients with moderate-to-severe asthma." @default.
• W1990444499 created "2016-06-24" @default.
• W1990444499 creator A5021417774 @default.
• W1990444499 creator A5030251330 @default.
• W1990444499 creator A5070796582 @default.
• W1990444499 creator A5090233358 @default.
• W1990444499 creator A5090361453 @default.
• W1990444499 date "2013-02-01" @default.
• W1990444499 modified "2023-10-14" @default.
• W1990444499 title "Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma" @default.
• W1990444499 cites W128731631 @default.
• W1990444499 cites W132708973 @default.
• W1990444499 cites W1795103282 @default.
• W1990444499 cites W1968405264 @default.
• W1990444499 cites W1970048937 @default.
• W1990444499 cites W1974042832 @default.
• W1990444499 cites W1981099046 @default.
• W1990444499 cites W1985171602 @default.
• W1990444499 cites W1987062528 @default.
• W1990444499 cites W1989813987 @default.
• W1990444499 cites W1990602199 @default.
• W1990444499 cites W2000366267 @default.
• W1990444499 cites W2025409168 @default.
• W1990444499 cites W2027285152 @default.
• W1990444499 cites W2063045365 @default.
• W1990444499 cites W2075324875 @default.
• W1990444499 cites W2076544702 @default.
• W1990444499 cites W2083269086 @default.
• W1990444499 cites W2085559912 @default.
• W1990444499 cites W2098633046 @default.
• W1990444499 cites W2100197717 @default.
• W1990444499 cites W2110658984 @default.
• W1990444499 cites W2115012618 @default.
• W1990444499 cites W2125078269 @default.
• W1990444499 cites W2128177638 @default.
• W1990444499 cites W2134619734 @default.
• W1990444499 cites W2145513806 @default.
• W1990444499 cites W2147349084 @default.
• W1990444499 cites W2148583736 @default.
• W1990444499 cites W2152288064 @default.
• W1990444499 cites W2153236387 @default.
• W1990444499 cites W2161390117 @default.
• W1990444499 cites W2166915032 @default.
• W1990444499 cites W2167495641 @default.
• W1990444499 cites W2169949930 @default.
• W1990444499 cites W2171331726 @default.
• W1990444499 cites W2331287401 @default.
• W1990444499 cites W8081792 @default.
• W1990444499 doi "https://doi.org/10.1016/j.rmed.2012.10.025" @default.
• W1990444499 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23273405" @default.
• W1990444499 hasPublicationYear "2013" @default.
• W1990444499 type Work @default.
• W1990444499 sameAs 1990444499 @default.
• W1990444499 citedByCount "45" @default.
• W1990444499 countsByYear W19904444992013 @default.
• W1990444499 countsByYear W19904444992014 @default.
• W1990444499 countsByYear W19904444992015 @default.
• W1990444499 countsByYear W19904444992016 @default.
• W1990444499 countsByYear W19904444992017 @default.
• W1990444499 countsByYear W19904444992018 @default.
• W1990444499 countsByYear W19904444992019 @default.
• W1990444499 countsByYear W19904444992020 @default.
• W1990444499 countsByYear W19904444992021 @default.
• W1990444499 countsByYear W19904444992022 @default.
• W1990444499 countsByYear W19904444992023 @default.
• W1990444499 crossrefType "journal-article" @default.
• W1990444499 hasAuthorship W1990444499A5021417774 @default.
• W1990444499 hasAuthorship W1990444499A5030251330 @default.
• W1990444499 hasAuthorship W1990444499A5070796582 @default.
• W1990444499 hasAuthorship W1990444499A5090233358 @default.
• W1990444499 hasAuthorship W1990444499A5090361453 @default.
• W1990444499 hasBestOaLocation W19904444991 @default.
• W1990444499 hasConcept C126322002 @default.
• W1990444499 hasConcept C142724271 @default.
• W1990444499 hasConcept C168563851 @default.
• W1990444499 hasConcept C19720800 @default.
• W1990444499 hasConcept C197934379 @default.
• W1990444499 hasConcept C203092338 @default.
• W1990444499 hasConcept C204787440 @default.
• W1990444499 hasConcept C27081682 @default.
• W1990444499 hasConcept C2776042228 @default.
• W1990444499 hasConcept C2776136866 @default.
• W1990444499 hasConcept C2776804153 @default.
• W1990444499 hasConcept C2779028295 @default.
• W1990444499 hasConcept C2779871671 @default.
• W1990444499 hasConcept C2780261241 @default.
• W1990444499 hasConcept C2781018748 @default.
• W1990444499 hasConcept C2781212218 @default.
• W1990444499 hasConcept C2909086917 @default.
• W1990444499 hasConcept C42219234 @default.
• W1990444499 hasConcept C71924100 @default.
• W1990444499 hasConceptScore W1990444499C126322002 @default.
• W1990444499 hasConceptScore W1990444499C142724271 @default.
• W1990444499 hasConceptScore W1990444499C168563851 @default.
• W1990444499 hasConceptScore W1990444499C19720800 @default.
• W1990444499 hasConceptScore W1990444499C197934379 @default.
• W1990444499 hasConceptScore W1990444499C203092338 @default.
• W1990444499 hasConceptScore W1990444499C204787440 @default.

• next